SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038876
Filing Date
2019-08-09
Accepted
2019-08-09 16:04:26
Documents
108
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv525903_10q.htm 10-Q 1322986
2 EXHIBIT 31.1 tv525903_ex31-1.htm EX-31.1 10905
3 EXHIBIT 31.2 tv525903_ex31-2.htm EX-31.2 10743
4 EXHIBIT 32.1 tv525903_ex32-1.htm EX-32.1 4213
5 EXHIBIT 32.2 tv525903_ex32-2.htm EX-32.2 4152
  Complete submission text file 0001144204-19-038876.txt   13644605

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fbio-20190630.xml EX-101.INS 4398325
7 XBRL TAXONOMY EXTENSION SCHEMA fbio-20190630.xsd EX-101.SCH 112652
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20190630_cal.xml EX-101.CAL 111491
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20190630_def.xml EX-101.DEF 327406
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20190630_lab.xml EX-101.LAB 688457
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20190630_pre.xml EX-101.PRE 636057
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 191012971
SIC: 2834 Pharmaceutical Preparations